Agios Pharmaceuticals Inc (AGIO)
29.52
+0.09
(+0.31%)
USD |
NASDAQ |
Apr 19, 16:00
29.52
0.00 (0.00%)
After-Hours: 19:04
Agios Pharmaceuticals Total Liabilities (Quarterly): 126.10M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 126.10M |
| September 30, 2023 | 120.42M |
| June 30, 2023 | 120.92M |
| March 31, 2023 | 114.77M |
| December 31, 2022 | 137.90M |
| September 30, 2022 | 130.15M |
| June 30, 2022 | 128.40M |
| March 31, 2022 | 128.41M |
| December 31, 2021 | 145.76M |
| September 30, 2021 | 146.74M |
| June 30, 2021 | 152.79M |
| March 31, 2021 | 191.80M |
| December 31, 2020 | 453.45M |
| September 30, 2020 | 428.00M |
| June 30, 2020 | 417.68M |
| March 31, 2020 | 174.44M |
| December 31, 2019 | 250.21M |
| September 30, 2019 | 250.32M |
| June 30, 2019 | 251.19M |
| March 31, 2019 | 201.87M |
| December 31, 2018 | 170.92M |
| September 30, 2018 | 168.87M |
| June 30, 2018 | 175.09M |
| Date | Value |
|---|---|
| March 31, 2018 | 174.53M |
| December 31, 2017 | 238.89M |
| September 30, 2017 | 237.39M |
| June 30, 2017 | 251.61M |
| March 31, 2017 | 249.94M |
| December 31, 2016 | 260.50M |
| September 30, 2016 | 270.59M |
| June 30, 2016 | 268.52M |
| March 31, 2016 | 63.74M |
| December 31, 2015 | 74.95M |
| September 30, 2015 | 73.43M |
| June 30, 2015 | 70.22M |
| March 31, 2015 | 47.52M |
| December 31, 2014 | 67.54M |
| September 30, 2014 | 61.86M |
| June 30, 2014 | 71.48M |
| March 31, 2014 | 60.57M |
| December 31, 2013 | 69.72M |
| September 30, 2013 | 76.47M |
| June 30, 2013 | 82.38M |
| March 31, 2013 | 88.73M |
| December 31, 2012 | 93.11M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
114.77M
Minimum
Mar 2023
453.45M
Maximum
Dec 2020
203.65M
Average
146.74M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 4.051B |
| Blueprint Medicines Corp | 918.64M |
| Corcept Therapeutics Inc | 114.81M |
| Ionis Pharmaceuticals Inc | 2.603B |
| Madrigal Pharmaceuticals Inc | 235.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 937.12M |
| Shareholders Equity (Quarterly) | 811.02M |
| Current Ratio | 12.27 |